glucose, (beta-d)-isomer has been researched along with Cytokine Release Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakos, T; Barta, BA; Kökény, G; Kozma, GT; Merkely, B; Mészáros, T; Nagy, GV; Radovits, T; Szabó, A; Szebeni, J | 1 |
| Bakos, T; Kozma, GT; Szebeni, J; Szénási, G | 1 |
2 other study(ies) available for glucose, (beta-d)-isomer and Cytokine Release Syndrome
| Article | Year |
|---|---|
Zymosan Particle-Induced Hemodynamic, Cytokine and Blood Cell Changes in Pigs: An Innate Immune Stimulation Model with Relevance to Cytokine Storm Syndrome and Severe COVID-19.
Topics: Animals; COVID-19; Cytokine Release Syndrome; Cytokines; Immunity, Innate; Interleukin-6; Leukocytes, Mononuclear; Swine; Zymosan | 2023 |
Eculizumab suppresses zymosan-induced release of inflammatory cytokines IL-1α, IL-1β, IFN-γ and IL-2 in autologous serum-substituted PBMC cultures: Relevance to cytokine storm in Covid-19.
Topics: COVID-19; Cytokine Release Syndrome; Cytokines; Humans; Interferon-gamma; Interleukin-2; Interleukin-8; Leukocytes, Mononuclear; Zymosan | 2023 |